Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 24 06 2021
accepted: 15 09 2023
medline: 10 11 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Noncoding variants of presumed regulatory function contribute to the heritability of neuropsychiatric disease. A total of 2,221 noncoding variants connected to risk for ten neuropsychiatric disorders, including autism spectrum disorder, attention deficit hyperactivity disorder, bipolar disorder, borderline personality disorder, major depression, generalized anxiety disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder and schizophrenia, were studied in developing human neural cells. Integrating epigenomic and transcriptomic data with massively parallel reporter assays identified differentially-active single-nucleotide variants (daSNVs) in specific neural cell types. Expression-gene mapping, network analyses and chromatin looping nominated candidate disease-relevant target genes modulated by these daSNVs. Follow-up integration of daSNV gene editing with clinical cohort analyses suggested that magnesium transport dysfunction may increase neuropsychiatric disease risk and indicated that common genetic pathomechanisms may mediate specific symptoms that are shared across multiple neuropsychiatric diseases.

Identifiants

pubmed: 37857935
doi: 10.1038/s41588-023-01533-5
pii: 10.1038/s41588-023-01533-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1876-1891

Subventions

Organisme : NIA NIH HHS
ID : R01 AG066490
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH125244
Pays : United States

Informations de copyright

© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
pmcid: 4112379 doi: 10.1038/nature13595
PsychENCODE Consortium et al.The PsychENCODE project. Nat. Neurosci. 18, 1707–1712 (2015).
doi: 10.1038/nn.4156
Ombrato, L. et al. Metastatic-niche labelling reveals parenchymal cells with stem features. Nature 572, 603–608 (2019).
pubmed: 31462798 pmcid: 6797499 doi: 10.1038/s41586-019-1487-6
Witt, S. H. et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl. Psychiatry 7, e1155 (2017).
pubmed: 28632202 pmcid: 5537640 doi: 10.1038/tp.2017.115
Meier, S. M. et al. Genetic variants associated with anxiety and stress-related disorders: a genome-wide association study and mouse-model study. JAMA Psychiatry 76, 924–932 (2019).
pubmed: 31116379 pmcid: 6537792 doi: 10.1001/jamapsychiatry.2019.1119
Tam, V. et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet. 20, 467–484 (2019).
pubmed: 31068683 doi: 10.1038/s41576-019-0127-1
Zhang, F. & Lupski, J. R. Non-coding genetic variants in human disease. Hum. Mol. Genet. 24, R102–R110 (2015).
pubmed: 26152199 pmcid: 4572001 doi: 10.1093/hmg/ddv259
Won, H. et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538, 523–527 (2016).
pubmed: 27760116 pmcid: 5358922 doi: 10.1038/nature19847
Gandal, M. J. et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359, 693–697 (2018).
pubmed: 29439242 pmcid: 5898828 doi: 10.1126/science.aad6469
Mulvey, B., Lagunas, T. & Dougherty, J. D. Massively parallel reporter assays: defining functional psychiatric genetic variants across biological contexts. Biol. Psychiatry 89, 76–89 (2021).
pubmed: 32843144 doi: 10.1016/j.biopsych.2020.06.011
Tewhey, R. et al. Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell 165, 1519–1529 (2016).
pubmed: 27259153 pmcid: 4957403 doi: 10.1016/j.cell.2016.04.027
Ulirsch, J. C. et al. Systematic functional dissection of common genetic variation affecting red blood cell traits. Cell 165, 1530–1545 (2016).
pubmed: 27259154 pmcid: 4893171 doi: 10.1016/j.cell.2016.04.048
Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
doi: 10.1038/ng.2653
Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785–798 (2013).
pubmed: 23764284 pmcid: 3751803 doi: 10.1016/j.neuron.2013.05.029
Ashuach, T. et al. MPRAnalyze: statistical framework for massively parallel reporter assays. Genome Biol. 20, 183 (2019).
pubmed: 31477158 pmcid: 6717970 doi: 10.1186/s13059-019-1787-z
Zhou, J. et al. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat. Genet. 50, 1171–1179 (2018).
pubmed: 30013180 pmcid: 6094955 doi: 10.1038/s41588-018-0160-6
Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC–seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.1–9 (2015).
pubmed: 25559105
Mumbach, M. R. et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat. Methods 13, 919–922 (2016).
pubmed: 27643841 pmcid: 5501173 doi: 10.1038/nmeth.3999
Song, M. et al. Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes. Nat. Genet. 51, 1252–1262 (2019).
pubmed: 31367015 pmcid: 6677164 doi: 10.1038/s41588-019-0472-1
Zhang, S. et al. Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. Science 369, 561–565 (2020).
pubmed: 32732423 pmcid: 7773145 doi: 10.1126/science.aay3983
Inoue, F. et al. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity.Genome Res. 27, 38–52 (2017).
pubmed: 27831498 pmcid: 5204343 doi: 10.1101/gr.212092.116
Herdegen, T. & Waetzig, V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20, 2424–2437 (2001).
pubmed: 11402338 doi: 10.1038/sj.onc.1204387
Chew, L. J. et al. Sox17 regulates a program of oligodendrocyte progenitor cell expansion and differentiation during development and repair. Cell Rep. 29, 3173–3186 (2019).
pubmed: 31801081 pmcid: 7191642 doi: 10.1016/j.celrep.2019.10.121
Ruiz i Altaba, A., Palma, V. & Dahmane, N. Hedgehog–GLI signaling and the growth of the brain. Nat. Rev. Neurosci. 3, 24–33 (2002).
pubmed: 11823802 doi: 10.1038/nrn704
Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).
pubmed: 29632380 pmcid: 5896795 doi: 10.1038/s41588-018-0081-4
Skene, N. G. et al. Genetic identification of brain cell types underlying schizophrenia. Nat. Genet. 50, 825–833 (2018).
pubmed: 29785013 pmcid: 6477180 doi: 10.1038/s41588-018-0129-5
Hook, P. W. & McCallion, A. S. Leveraging mouse chromatin data for heritability enrichment informs common disease architecture and reveals cortical layer contributions to schizophrenia. Genome Res. 30, 528–539 (2020).
pubmed: 32303558 pmcid: 7197474 doi: 10.1101/gr.256578.119
Bulik-Sullivan, B. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Wang, D. et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 362, eaat8464 (2018).
pubmed: 30545857 pmcid: 6413328 doi: 10.1126/science.aat8464
Kinney, D. K. et al. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Med. Hypotheses 74, 555–563 (2010).
pubmed: 19836903 doi: 10.1016/j.mehy.2009.09.040
Shao, Z. et al. Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia. Nat. Neurosci. 22, 229–242 (2019).
pubmed: 30664768 pmcid: 6373728 doi: 10.1038/s41593-018-0313-z
Hoseth, E. Z. et al. Attenuated Notch signaling in schizophrenia and bipolar disorder. Sci. Rep. 8, 5349 (2018).
pubmed: 29593239 pmcid: 5871764 doi: 10.1038/s41598-018-23703-w
Onwordi, E. C. et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat. Commun. 11, 246 (2020).
pubmed: 31937764 pmcid: 6959348 doi: 10.1038/s41467-019-14122-0
Yabut, O. R., Fernandez, G., Huynh, T., Yoon, K. & Pleasure, S. J. Suppressor of fused is critical for maintenance of neuronal progenitor identity during corticogenesis. Cell Rep. 12, 2021–2034 (2015).
pubmed: 26387942 pmcid: 4591209 doi: 10.1016/j.celrep.2015.08.031
Nord, A. S., Pattabiraman, K., Visel, A. & Rubenstein, J. L. R. Genomic perspectives of transcriptional regulation in forebrain development. Neuron 85, 27–47 (2015).
pubmed: 25569346 pmcid: 4438709 doi: 10.1016/j.neuron.2014.11.011
Zhang, S. et al. OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor. Stem Cell Res. Ther. 10, 122 (2019).
pubmed: 30999923 pmcid: 6471829 doi: 10.1186/s13287-019-1228-7
Hodge, R. D. et al. Conserved cell types with divergent features in human versus mouse cortex. Nature 573, 61–68 (2019).
pubmed: 31435019 pmcid: 6919571 doi: 10.1038/s41586-019-1506-7
Nichol, H., Amilhon, B., Manseau, F., Badrinarayanan, S. & Williams, S. Electrophysiological and morphological characterization of Chrna2 cells in the subiculum and Ca1 of the hippocampus: an optogenetic investigation. Front. Cell. Neurosci. 12, 32 (2018).
pubmed: 29487503 pmcid: 5816824 doi: 10.3389/fncel.2018.00032
Giralt, A. et al. Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington’s disease model. Nat. Commun. 8, 15592 (2017).
pubmed: 28555636 pmcid: 5459995 doi: 10.1038/ncomms15592
Arjona, F. J. et al. CNNM2 mutations cause impaired brain development and seizures in patients with hypomagnesemia. PLoS Genet. 10, 1004267 (2014).
doi: 10.1371/journal.pgen.1004267
Li, M. et al. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nat. Med. 22, 649–656 (2016).
pubmed: 27158905 doi: 10.1038/nm.4096
Franken, G. A. C. et al. Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects. Sci. Rep. 11, 8217 (2021).
pubmed: 33859252 pmcid: 8050252 doi: 10.1038/s41598-021-87548-6
Adam, M. P., Mirzaa, G. M., Pagon, R. A., Wallace, S.E., Bean, L. J. H., Gripp, K. W. & Amemiya, A. (eds.). GeneReviews (University of Washington, 1993).
Katsuki, A. et al. A single-nucleotide polymorphism influences brain morphology in drug-näve patients with major depressive disorder. Neuropsychiatr. Dis. Treat. 15, 2425–2432 (2019).
pubmed: 31692503 pmcid: 6711561 doi: 10.2147/NDT.S204461
Logan, T. T., Rusnak, M. & Symes, A. J. Runx1 promotes proliferation and neuronal differentiation in adult mouse neurosphere cultures. Stem Cell Res. 15, 554–564 (2015).
pubmed: 26473321 doi: 10.1016/j.scr.2015.09.014
Singh, T., Neale, B. M., Daly, M. J. et al. Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia. Preprint at medRxiv https://doi.org/10.1101/2020.09.18.20192815 (2022).
Andrade, A. et al. Genetic associations between voltage-gated calcium channels and psychiatric disorders. Int. J. Mol. Sci. 20, 3537 (2019).
pubmed: 31331039 pmcid: 6679227 doi: 10.3390/ijms20143537
Davis, K. A. S. et al. Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis. BJPsych Open 6, e18 (2020).
pubmed: 32026800 pmcid: 7176892 doi: 10.1192/bjo.2019.100
Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437–1452 (2017).
pubmed: 29195078 pmcid: 5990023 doi: 10.1016/j.cell.2017.10.049
Yaghoobi, M. M., Mowla, S. J. & Tiraihi, T. Nucleostemin, a coordinator of self-renewal, is expressed in rat marrow stromal cells and turns off after induction of neural differentiation. Neurosci. Lett. 390, 81–86 (2005).
pubmed: 16139428 doi: 10.1016/j.neulet.2005.08.011
Teng, X. et al. KCTD: a new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neurosci. Ther. 25, 887–902 (2019).
pubmed: 31197948 pmcid: 6566181 doi: 10.1111/cns.13156
Imbrici, P., Camerino, D. C. & Tricarico, D. Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front. Genet. 4, 76 (2013).
pubmed: 23675382 pmcid: 3646240 doi: 10.3389/fgene.2013.00076
Meng, Q. et al. Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder. Mol. Psychiatry 25, 2672–2684 (2020).
pubmed: 32826963 doi: 10.1038/s41380-020-00866-5
Eby, G. A. & Eby, K. L. Rapid recovery from major depression using magnesium treatment. Med. Hypotheses 67, 362–370 (2006).
pubmed: 16542786 doi: 10.1016/j.mehy.2006.01.047
Myint, L. et al. Testing the regulatory consequences of 1,049 schizophrenia associated variants with a massively parallel reporter assay. Preprint at bioRxiv https://doi.org/10.1101/447557 (2019).
Calakos, N. et al. Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia. J. Med. Genet. 47, 646–650 (2010).
pubmed: 19955557 doi: 10.1136/jmg.2009.072082
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
pubmed: 30445434 doi: 10.1093/nar/gky1120
Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
pubmed: 29165669 doi: 10.1093/nar/gkx1153
Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F. & Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43, D789–D798 (2015).
pubmed: 25428349 doi: 10.1093/nar/gku1205
Ward, L. D. & Kellis, M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 44, D877–D881 (2016).
pubmed: 26657631 doi: 10.1093/nar/gkv1340
De Souza, N. The ENCODE project. Nat. Methods 9, 1046 (2012).
pubmed: 23281567 doi: 10.1038/nmeth.2238
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886–D894 (2019).
pubmed: 30371827 doi: 10.1093/nar/gky1016
Du, Z. W. et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 6, 6626 (2015).
pubmed: 25806427 doi: 10.1038/ncomms7626
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286 pmcid: 3322381 doi: 10.1038/nmeth.1923
Kim, D. et al. The dynamic, combinatorial cis-regulatory lexicon of epidermal differentiation. Nat. Genet. 53, 1564–1576 (2021).
pubmed: 34650237 pmcid: 8763320 doi: 10.1038/s41588-021-00947-3
Kim, H. K. et al. Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity. Nat. Biotechnol. 36, 239–241 (2018).
pubmed: 29431740 doi: 10.1038/nbt.4061
Concordet, J. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, 242–245 (2018).
doi: 10.1093/nar/gky354
Gasperini, M. et al. A genome-wide framework for mapping gene regulation via cellular genetic screens. Cell 176, 377–390 (2019).
pubmed: 30612741 pmcid: 6690346 doi: 10.1016/j.cell.2018.11.029
Labun, K., Montague, T. G., Krause, M., Cleuren, Y. N. T. & Valen, E. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, 171–174 (2019).
doi: 10.1093/nar/gkz365
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
pubmed: 21816040 pmcid: 3163565 doi: 10.1186/1471-2105-12-323
Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193–1203 (2016).
pubmed: 27526324 pmcid: 5042844 doi: 10.1038/ng.3646
Servant, N. et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 16, 259 (2015).
pubmed: 26619908 pmcid: 4665391 doi: 10.1186/s13059-015-0831-x
Lareau, C. A. & Aryee, M. J. Hichipper: a preprocessing pipeline for calling DNA loops from HiChIP data. Nat. Methods 15, 155–156 (2018).
pubmed: 29489746 pmcid: 10572103 doi: 10.1038/nmeth.4583
Bhattacharyya, S., Chandra, V., Vijayanand, P. & Ay, F. FitHiChIP: identification of significant chromatin contacts from HiChIP data. Preprint at bioRxiv https://doi.org/10.1101/412833 (2018).
Li, Z. et al. Identification of transcription factor binding sites using ATAC–seq. Genome Biol. 20, 45 (2019).
pubmed: 30808370 pmcid: 6391789 doi: 10.1186/s13059-019-1642-2
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Donohue, L. K. H. et al. A cis-regulatory lexicon of DNA motif combinations mediating cell-type-specific gene regulation. Cell Genom. 2, 100191 (2022).
pubmed: 36742369 pmcid: 9894309 doi: 10.1016/j.xgen.2022.100191
Szklarczyk, D. et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607–D613 (2019).
pubmed: 30476243 doi: 10.1093/nar/gky1131
Welch, J. D. et al. Single-cell multi-omic integration compares and contrasts features of brain cell identity. Cell 177, 1873–1887 (2019).
pubmed: 31178122 pmcid: 6716797 doi: 10.1016/j.cell.2019.05.006
Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).
pubmed: 23586463 pmcid: 3637064 doi: 10.1186/1471-2105-14-128
Singh, T. et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, 509–516 (2022).
pubmed: 35396579 pmcid: 9805802 doi: 10.1038/s41586-022-04556-w
Ghandi, M., Lee, D., Mohammad-Noori, M. & Beer, M. A. Enhanced regulatory sequence prediction using gapped k-mer features. PLoS Comput. Biol. 10, 1003711 (2014).
doi: 10.1371/journal.pcbi.1003711
Ang, C. E. et al. The dynamic interplay between homeodomain transcription factors and chromatin environment regulates proneural factor outcomes. Preprint at bioRxiv https://doi.org/10.1101/2020.12.02.398677 (2020).
mguo123. mguo123/pan_omics_psych: publication release. Zenodo. https://zenodo.org/record/8098407 (2023).
mguo123. mugo123/psych_mpra: publication release. Zenodo. https://zenodo.org/record/8098409 (2023).
Duncan L, Yilmaz Z, Gaspar H, et al. Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa. Am. J. Psychiatry 174, 850–858 (2017).
Demontis, D., Walters, R.K., Martin, J. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
Grove, J., Ripke, S., Als, T.D. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Electronic address: douglas.ruderfer@vanderbilt.edu; Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell 173, 1705–1715 (2018).
Stahl, E.A., Breen, G., Forstner, A.J. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803 (2019).
Pardiñas, A.F., Holmans, P., Pocklington, A.J. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
Wray, N.R., Ripke, S., Mattheisen, M. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
Howard, D.M., Adams, M.J., Clarke, TK. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019).
Nagel, M., Jansen, P.R., Stringer, S. et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat. Genet. 50, 920–927 (2018).
International League Against Epilepsy Consortium on Complex Epilepsies. Electronic address: epilepsy-austin@unimelb.edu.au. Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. Lancet Neurol. 13, 893–903 (2014).
Jansen, I.E., Savage, J.E., Watanabe, K. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
Marioni, R.E., Harris, S.E., Zhang, Q. et al. GWAS on family history of Alzheimer’s disease. Transl. Psychiatry 8, 99 (2018).
Corces, M.R., Shcherbina, A., Kundu, S. et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases. Nat Genet 52, 1158–1168 (2020).
Ferreira MAR, Mathur R, Vonk JM, et al. Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. Am J Hum Genet. 104, 665–684 (2019).
de Lange, K., Moutsianas, L., Lee, J. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49, 256–261 (2017).

Auteurs

Margaret G Guo (MG)

Stanford Program in Biomedical Informatics, Stanford University, Stanford, CA, USA.
Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

David L Reynolds (DL)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

Cheen E Ang (CE)

Department of Pathology, Stanford University, Stanford, CA, USA.
Department of Bioengineering, Stanford University, Stanford, CA, USA.
Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.

Yingfei Liu (Y)

Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.
Institute of Neurobiology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Yang Zhao (Y)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

Laura K H Donohue (LKH)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.
Department of Genetics, Stanford University, Stanford, CA, USA.

Zurab Siprashvili (Z)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

Xue Yang (X)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.
Stanford Program in Cancer Biology, Stanford University, Stanford, CA, USA.

Yongjin Yoo (Y)

Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.

Smarajit Mondal (S)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

Audrey Hong (A)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.

Jessica Kain (J)

Department of Genetics, Stanford University, Stanford, CA, USA.

Lindsey Meservey (L)

Department of Biology, Stanford University, Stanford, CA, USA.

Tania Fabo (T)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.
Department of Genetics, Stanford University, Stanford, CA, USA.

Ibtihal Elfaki (I)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.
Department of Genetics, Stanford University, Stanford, CA, USA.

Laura N Kellman (LN)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA.
Stanford Program in Cancer Biology, Stanford University, Stanford, CA, USA.

Nathan S Abell (NS)

Department of Genetics, Stanford University, Stanford, CA, USA.

Yash Pershad (Y)

Department of Bioengineering, Stanford University, Stanford, CA, USA.

Vafa Bayat (V)

Bitscopic Inc., Los Angeles, CA, USA.

Payam Etminani (P)

Bitscopic Inc., Los Angeles, CA, USA.

Mark Holodniy (M)

Public Health Surveillance and Research, Department of Veterans Affairs, Washington, DC, USA.
Division of Infectious Disease & Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Daniel H Geschwind (DH)

Program in Neurobehavioral Genetics, Semel Institute, UCLA, Los Angeles, CA, USA.

Stephen B Montgomery (SB)

Department of Pathology, Stanford University, Stanford, CA, USA.
Department of Genetics, Stanford University, Stanford, CA, USA.

Laramie E Duncan (LE)

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.

Alexander E Urban (AE)

Department of Genetics, Stanford University, Stanford, CA, USA.
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.

Russ B Altman (RB)

Stanford Program in Biomedical Informatics, Stanford University, Stanford, CA, USA.
Department of Bioengineering, Stanford University, Stanford, CA, USA.
Department of Genetics, Stanford University, Stanford, CA, USA.

Marius Wernig (M)

Department of Pathology, Stanford University, Stanford, CA, USA.
Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.

Paul A Khavari (PA)

Program in Epithelial Biology, Stanford University, Stanford, CA, USA. khavari@stanford.edu.
Stanford Program in Cancer Biology, Stanford University, Stanford, CA, USA. khavari@stanford.edu.
Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, USA. khavari@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH